Gene · 3741
Papers2,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a novel competing endogenous RNA network and candidate drugs associated with ferroptosis in aldosterone-producing adenomas. | Aging (Albany NY) | 2023 | 37709486 | PubTator, text mining | PubMed |
| Identification of molecular subgroups and establishment of risk model based on the response to oxidative stress to predict overall survival of patients with lung adenocarcinoma. | Eur J Med Res | 2023 | 37689745 | PubTator, text mining | PubMed |
| Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome. | Cells | 2023 | 37681921 | PubTator, text mining | PubMed |
| Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development. | Cardiovasc Res | 2023 | 37677054 | PubTator, text mining | PubMed |
| Highly enantioselective Rh-catalyzed asymmetric reductive dearomatization of multi-nitrogen polycyclic pyrazolo[1,5-a]pyrimidines. | Chem Sci | 2023 | 37655036 | PubTator, text mining | PubMed |
| Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. | J Clin Med | 2023 | 37629337 | PubTator, text mining | PubMed |
| Tic-Tac: A Translational Approach in Mechanisms Associated with Irregular Heartbeat and Sinus Rhythm Restoration in Atrial Fibrillation Patients. | Int J Mol Sci | 2023 | 37629037 | PubTator, text mining | PubMed |
| Cytochalasans and Their Impact on Actin Filament Remodeling. | Biomolecules | 2023 | 37627312 | PubTator, text mining | PubMed |
| Obesity-Related Atrial Fibrillation: Cardiac Manifestation of a Systemic Disease. | J Cardiovasc Dev Dis | 2023 | 37623336 | PubTator, text mining | PubMed |
| Schizosaccharomyces pombe Rtf2 is important for replication fork barrier activity of RTS1 via splicing of Rtf1. | Elife | 2023 | 37615341 | PubTator, text mining | PubMed |
| Lurasidone blocks the voltage-gated potassium channels of coronary arterial smooth muscle cells. | Eur J Pharmacol | 2023 | 37611842 | PubTator, text mining | PubMed |
| Cardiac Arrest From Undiagnosed Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report. | Cureus | 2023 | 37602051 | PubTator, text mining | PubMed |
| Fushenmu treatment ameliorates RyR2 with related metabolites in a zebrafish model of barium chloride induced arrhythmia. | Chin Med | 2023 | 37598173 | PubTator, text mining | PubMed |
| Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity. | Int J Mol Sci | 2023 | 37569725 | PubTator, text mining | PubMed |
| Inhibition of voltage-dependent K+ currents of rabbit coronary arterial smooth muscle cells by the atypical antipsychotic paliperidone. | J Appl Toxicol | 2023 | 37551856 | PubTator, text mining | PubMed |
| KV Channel-Interacting Proteins in the Neurological and Cardiovascular Systems: An Updated Review. | Cells | 2023 | 37508558 | PubTator, text mining | PubMed |
| Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia. | Stem Cell Res Ther | 2023 | 37501071 | PubTator, text mining | PubMed |
| Advancements in the study of inward rectifying potassium channels on vascular cells. | Channels (Austin) | 2023 | 37463317 | PubTator, text mining | PubMed |
| Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. | J Transl Med | 2023 | 37461108 | PubTator, text mining | PubMed |
| Propofol in ICU Settings: Understanding and Managing Anti-Arrhythmic, Pro-Arrhythmic Effects, and Propofol Infusion Syndrome. | Cureus | 2023 | 37456460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3741/papers?page=7